Literature DB >> 9086140

A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections.

J F Bohnsack1, K Widjaja, S Ghazizadeh, C E Rubens, D R Hillyard, C J Parker, K H Albertine, H R Hill.   

Abstract

Congenic C5-deficient and C5-sufficient mice were infected with group B streptococci (GBS) to determine if the polymorphonuclear leukocyte (PMNL) chemoattractant C5a contributes to PMNL recruitment in GBS infection and if GBS C5a-ase reduces C5a-induced PMNL recruitment in vivo. PMNL accumulation was greater in the peritoneum and air spaces of C5-sufficient mice than in C5-deficient mice. Administration of human C5 to C5-deficient mice caused a significant increase in PMNL recruitment following infection with C5a-ase-negative GBS. GBS C5a-ase did not reduce PMNL accumulation in C5-sufficient mice but reduced PMNL recruitment in C5-deficient mice reconstituted with human C5. These data indicate that C5a is important for rapid PMNL recruitment to sites of GBS infection and that GBS C5a-ase inactivates human, but not murine, C5a in vivo. Reduction of the acute inflammatory response by C5a-ase likely contributes to GBS virulence in human neonates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9086140     DOI: 10.1086/513981

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Capsular sialic acid limits C5a production on type III group B streptococci.

Authors:  S Takahashi; Y Aoyagi; E E Adderson; Y Okuwaki; J F Bohnsack
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 2.  The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent Pathogen.

Authors:  Blair Armistead; Elizabeth Oler; Kristina Adams Waldorf; Lakshmi Rajagopal
Journal:  J Mol Biol       Date:  2019-01-31       Impact factor: 5.469

Review 3.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Functional basis for complement evasion by staphylococcal superantigen-like 7.

Authors:  Jovanka Bestebroer; Piet C Aerts; Suzan H M Rooijakkers; Manoj K Pandey; Jörg Köhl; Jos A G van Strijp; Carla J C de Haas
Journal:  Cell Microbiol       Date:  2010-10       Impact factor: 3.715

5.  Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.

Authors:  Q Cheng; B Carlson; S Pillai; R Eby; L Edwards; S B Olmsted; P Cleary
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  The SrtA Sortase of Streptococcus agalactiae is required for cell wall anchoring of proteins containing the LPXTG motif, for adhesion to epithelial cells, and for colonization of the mouse intestine.

Authors:  Lila Lalioui; Elisabeth Pellegrini; Shaynoor Dramsi; Marina Baptista; Nadege Bourgeois; Florence Doucet-Populaire; Christophe Rusniok; Mohamed Zouine; Philippe Glaser; Frank Kunst; Claire Poyart; Patrick Trieu-Cuot
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.

Authors:  Qi Cheng; Steven Debol; Hong Lam; Ron Eby; Lorri Edwards; Yury Matsuka; Stephen B Olmsted; P Patrick Cleary
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  The group B streptococcal C5a peptidase is both a specific protease and an invasin.

Authors:  Qi Cheng; Deborah Stafslien; Sai Sudha Purushothaman; Patrick Cleary
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

9.  Human serum induces streptococcal c5a peptidase expression.

Authors:  Ute Gleich-Theurer; Simone Aymanns; Gregor Haas; Stefanie Mauerer; Julia Vogt; Barbara Spellerberg
Journal:  Infect Immun       Date:  2009-06-08       Impact factor: 3.441

10.  Streptococcus agalactiae CspA is a serine protease that inactivates chemokines.

Authors:  Joshua D Bryan; Daniel W Shelver
Journal:  J Bacteriol       Date:  2008-12-29       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.